Benedetta Apollonio Division of Molecular Oncology IRCCS, San Raffaele Scientific Institute Biography Publications Institution JoVE Articles Benedetta Apollonio has not added a biography. If you are Benedetta Apollonio and would like to personalize this page please email our Author Liaison for assistance. Publications SIGLEC-G Deficiency Increases Susceptibility to Develop B-cell Lymphoproliferative Disorders Haematologica. Aug, 2014 | Pubmed ID: 24859880 Targeting B-cell Anergy in Chronic Lymphocytic Leukemia Blood. May, 2013 | Pubmed ID: 23460614 Targeting the LYN/HS1 Signaling Axis in Chronic Lymphocytic Leukemia Blood. Mar, 2013 | Pubmed ID: 23325840 In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jan, 2013 | Pubmed ID: 23224401 Lack of TIR8/SIGIRR Triggers Progression of Chronic Lymphocytic Leukemia in Mouse Models Blood. Jul, 2011 | Pubmed ID: 21652674 A Novel Rag2-/-gammac-/--xenograft Model of Human CLL Blood. Feb, 2010 | Pubmed ID: 20018917 Monoclonal B Lymphocytosis in the General Population Leukemia & Lymphoma. Mar, 2009 | Pubmed ID: 19347732 Constitutive Activation of Distinct BCR-signaling Pathways in a Subset of CLL Patients: a Molecular Signature of Anergy Blood. Jul, 2008 | Pubmed ID: 18292287 D'un spot 2DE-Gel de la fonction des protéines: Leçons apprises De HS1 dans la leucémie lymphoïde chronique Benedetta Apollonio1,2, Maria Teresa Sabrina Bertilaccio1, Umberto Restuccia3, Pamela Ranghetti1, Federica Barbaglio1, Paolo Ghia1,4, Federico Caligaris-Cappio1,4, Cristina Scielzo1 1Division of Molecular Oncology, IRCCS, San Raffaele Scientific Institute, 2Department of Haemato-Oncology, King's College London, 3IFOM, FIRC Institute of Molecular Oncology, 4Università Vita-Salute San Raffaele JoVE 51942 Medicine
D'un spot 2DE-Gel de la fonction des protéines: Leçons apprises De HS1 dans la leucémie lymphoïde chronique Benedetta Apollonio1,2, Maria Teresa Sabrina Bertilaccio1, Umberto Restuccia3, Pamela Ranghetti1, Federica Barbaglio1, Paolo Ghia1,4, Federico Caligaris-Cappio1,4, Cristina Scielzo1 1Division of Molecular Oncology, IRCCS, San Raffaele Scientific Institute, 2Department of Haemato-Oncology, King's College London, 3IFOM, FIRC Institute of Molecular Oncology, 4Università Vita-Salute San Raffaele JoVE 51942 Medicine
